Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • Blog
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • Blog
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Assay test kits
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Assay test kits

[0149-36F2-100 Tests] Human CD36 antibody [Clone: CLB-IVC7], FITC conjug.ated - 100 tests
Human CD36 antibody [Clone: CLB-IVC7], FITC conjug.ated - 100 tests
704.00 € 704.0 EUR
[0763-E-EL-H6055] Human C2 (Complement Component 2) ELISA Test, 96 tests
Human C2 (Complement Component 2) ELISA Test, 96 tests
659.00 € 659.0 EUR
[0015-0040] Human C-peptide ELISA Test, 96 tests, Quantitative
Human C-peptide ELISA Test, 96 tests, Quantitative
810.00 € 810.0 EUR
[639-abx386564-96T] Human C-Type Lectin Domain Family 2 Member D (CLEC2D) ELISA Test - 96 tests
Human C-Type Lectin Domain Family 2 Member D (CLEC2D) ELISA Test - 96 tests
985.00 € 985.0 EUR
[0639-abx150982-96Tx33 szt] Human C-C Chemokine Receptor Type 3 (CCR3) ELISA Test - 96 tests x 33szt
Human C-C Chemokine Receptor Type 3 (CCR3) ELISA Test - 96 tests x 33szt
29,400.00 € 29400.0 EUR
[0513-DEIA1717] Human Borrelia burgdorferi IgM ELISA Test - 96 Tests
Human Borrelia burgdorferi IgM ELISA Test - 96 Tests
1,750.00 € 1750.0 EUR
[0015-930-100-TTG-96T] Human Anti-Tetanus Toxin/Toxoid IgG ELISA Test, 96 tests, Quantitative
Human Anti-Tetanus Toxin/Toxoid IgG ELISA Test, 96 tests, Quantitative
800.00 € 800.0 EUR
[0812-SL2281Hu] Human Anti-Tetanus Toxin IgG(TT-IgG)ELISA Test - 96 Tests
Human Anti-Tetanus Toxin IgG(TT-IgG)ELISA Test - 96 Tests
441.00 € 441.0 EUR
[0015-AE-321630-1] Human Anti-Sudan Ebola virus glycoprotein (GP) IgM ELISA Test, 96 tests, Quantitative
Human Anti-Sudan Ebola virus glycoprotein (GP) IgM ELISA Test, 96 tests, Quantitative
962.00 € 962.0 EUR
[0015-AE-321620-1] Human Anti-Sudan Ebola virus glycoprotein (GP) IgG ELISA Test, 96 tests, Quantitative
Human Anti-Sudan Ebola virus glycoprotein (GP) IgG ELISA Test, 96 tests, Quantitative
962.00 € 962.0 EUR
[0015-3300-110-SRG-96T] Human Anti-Smith antigen/RNP (Sm/RNP) IgG ELISA Test, 96 tests, Quantitative
Human Anti-Smith antigen/RNP (Sm/RNP) IgG ELISA Test, 96 tests, Quantitative
740.00 € 740.0 EUR
[0513-DEIA372] Human Anti-Polio Virus 1-3 IgG ELISA Test,96 tests
Human Anti-Polio Virus 1-3 IgG ELISA Test,96 tests
2,270.00 € 2270.0 EUR
[0639-abx055818] Human Anti-Onchocerca volvulus IgG ELISA Test - 96 Tests
Human Anti-Onchocerca volvulus IgG ELISA Test - 96 Tests
730.00 € 730.0 EUR
[0015-AE-322630-1] Human Anti-Marburg (Angola) glycoprotein (GP) IgM ELISA Test, 96 tests, Quantitative
Human Anti-Marburg (Angola) glycoprotein (GP) IgM ELISA Test, 96 tests, Quantitative
1,040.00 € 1040.0 EUR
[0015-AE-322620-1] Human Anti-Marburg (Angola) glycoprotein (GP) IgG ELISA Test, 96 tests, Quantitative
Human Anti-Marburg (Angola) glycoprotein (GP) IgG ELISA Test, 96 tests, Quantitative
1,040.00 € 1040.0 EUR
[0015-700-145-KLM] Human Anti-Keyhole limpet hemocyanin (KLH) IgM ELISA Test - 96 tests
Human Anti-Keyhole limpet hemocyanin (KLH) IgM ELISA Test - 96 tests
1,042.50 € 1042.5 EUR
[0015-700-140-KLG] Human Anti-Keyhole limpet hemocyanin (KLH) IgG ELISA Test - 96 tests
Human Anti-Keyhole limpet hemocyanin (KLH) IgG ELISA Test - 96 tests
980.00 € 980.0 EUR
[0015-4300] Human Anti-Hepatitis B Surface Antigen Pres-S1 (HB-Pre-S1) IgG ELISA Test - 96 tests, quantitative
Human Anti-Hepatitis B Surface Antigen Pres-S1 (HB-Pre-S1) IgG ELISA Test - 96 tests, quantitative
870.00 € 870.0 EUR
[0015-4200-96T] Human Anti-Hepatitis B Surface Antigen (anti-HBsAg) IgG ELISA Test (for vaccinated samples), 96 tests, quantitative
Human Anti-Hepatitis B Surface Antigen (anti-HBsAg) IgG ELISA Test (for vaccinated samples), 96 tests, quantitative
860.00 € 860.0 EUR
[0812-SL3523Hu] Human Anti-Haemophilus Influenzae Type B Antibody, Anti-Hib ELISA Test - 96 Tests
Human Anti-Haemophilus Influenzae Type B Antibody, Anti-Hib ELISA Test - 96 Tests
441.00 € 441.0 EUR
  • 25
  • 26
  • 27
  • 28
  • 29

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)